Back
United Therapeutics Stock Price Chart
The Next Tech Giant in Your Pocket?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
55
UTHR
United Therapeutics
Last Price:
352.27
Seasonality Move:
2.3%
7 Day Trial
ALL ACCESS PASS
$
7
How to Profit From "America's Earnings" Reports
New Trade Goes LIVE THIS TUESDAY at 2 pm- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and UTHR is experiencing buying pressure, which is a positive indicator for future bullish movement.
United Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 344.1 | Buy |
| 20-day SMA: | 348.89 | Buy |
| 50-day SMA: | 337.76 | Buy |
| 200-day SMA: | 270.17 | Buy |
| 8-day EMA: | 345.96 | Buy |
| 20-day EMA: | 345.13 | Buy |
| 50-day EMA: | 334.73 | Buy |
| 200-day EMA: | 286.49 | Buy |
United Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.37 | Buy |
| Relative Strength Index (14 RSI): | 56.89 | Buy |
| Chaikin Money Flow: | 259294 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (337.51 - 356.01) | Buy |
| Bollinger Bands (100): | (278.38 - 343.68) | Buy |
United Therapeutics Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for United Therapeutics Stock
Is United Therapeutics Stock a Buy?
- United Therapeutics share price is 351.33 while UTHR 8-day simple moving average is 344.10, which is a Buy signal.
- The stock price of UTHR is 351.33 while United Therapeutics 20-day SMA is 348.89, which makes it a Buy.
- United Therapeutics 50-day simple moving average is 337.76 while UTHR share price is 351.33, making it a Buy technically.
- UTHR stock price is 351.33 and United Therapeutics 200-day simple moving average is 270.17, creating a Buy signal.
UTHR Technical Analysis vs Fundamental Analysis
Buy
55
United Therapeutics (UTHR)
is a Buy
Is United Therapeutics a Buy or a Sell?
-
United Therapeutics stock is rated a Buy
The current United Therapeutics [UTHR] share price is $351.33. The Score for UTHR is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
United Therapeutics Stock Info
Market Cap:
15.63B
Price in USD:
351.33
Share Volume:
431.49K
United Therapeutics 52-Week Range
52-Week High:
366.08
52-Week Low:
208.62
Buy
55
United Therapeutics (UTHR)
is a Buy
United Therapeutics Share Price Forecast
-
What is the United Therapeutics stock price today?
The United Therapeutics stock price is 351.33 USD today. -
Will UTHR stock go up or go down?
United Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is United Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, United Therapeutics is not overvalued.
Is United Therapeutics Stock a Buy?
- United Therapeutics share price is 351.33 while UTHR 8-day exponential moving average is 345.96, which is a Buy signal.
- The stock price of UTHR is 351.33 while United Therapeutics 20-day EMA is 345.13, which makes it a Buy.
- United Therapeutics 50-day exponential moving average is 334.73 while UTHR share price is 351.33, making it a Buy technically.
- UTHR stock price is 351.33 and United Therapeutics 200-day simple moving average is 286.49, creating a Buy signal.
Fundamental Analysis of United Therapeutics
Is United Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $1.80 per share, a decrease next quarter of $0.00 per share, an increase this year of $5.87 per share, and an increase next year of $1.42 per share.
Technical Analysis of United Therapeutics
Should I short United Therapeutics stock?
- UTHR Moving Average Covergence Divergence (MACD) indicator is 2.37, suggesting United Therapeutics is a Buy
- United Therapeutics Relative Strength Index (RSI) is 56.89, which suggest United Therapeutics is overbought
- The Bollinger Bands (25) for United Therapeutics is (337.51 - 356.01), which suggest United Therapeutics is a Buy
- The Bollinger Bands (100) for United Therapeutics is (278.38 - 343.68), which suggest United Therapeutics is a Buy
* United Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.